View Report Details Global Human Growth Hormone Market Report ----------------------------------------2015
View Report Details Executive Summary
Pituitary - the master gland of human body is responsible for controlling crucial hormonal secretion, which, in turn, regulates other key aspects of the body such as temperature, growth, thyroid functioning, urination, and production of other hormones. It is a pea sized gland situated at the base of brain and is a major component of human body as it expedites the response towards the surrounding environment and settings.
Any deformity or damage to the pituitary gland can adversely impact the production and activity level of the above mentioned hormones, thereby affecting the body work process and stunting the outcomes especially in the case of growth hormone. Marred pituitary function leads to either over or under secretion of the somatropin that is the growth hormone. Its over secretion causes disfiguration in the body parts like hands, face, feet, etc. whereas, its deficiency impedes the growth of body parts/whole body, thus leading to disease states like dwarfism or gigantism.
It is observed that the growth hormone related problems usually affect children and teenagers, but it is seen to grip adults as well though to a lesser extent. The major factors which vitiate the pituitary operations thus impairing the GH role include kidney malfunction, tumors/cancer especially associated with brain. There are some other unknown causes as well which are termed as idiopathic. Earlier, to deal with these predicaments, growth hormone used to be extracted from the human cadavers but, as time passed and evolution of technology/tools/techniques/R&D took place, the extraction of GH also got altered and many novel innovations and discoveries were made in the respective field.
Nowadays, many leading companies are heavily involved in the R&D process for devising longer acting and sustained release versions of the somatropin which are produced using the recombinant technology. The competition prevalent in the respective industry is heating up day by day. The human growth hormone market is monopolized by a few players viz. Pfizer, NovoNordisk, Eli Lilly, Sandoz and Roche.
The global HGH report discusses the key ongoing trends like global agreement for Long-Acting Human Growth Hormone (HGH-CTP), increasing use of biosimilar version of drugs and continuous growth of recombinant growth hormones market. On the industry development front, the current inclination is towards developing better treatments for Alzheimer’s disease and advancements in needle free injections technology. Furthermore, the major factors driving the HGH market include rising cancer and CKD/ESRD cases and increasing healthcare expenditure on worldwide basis. In addition, a few factors posing challenges in front of the HGH industry are the problems in diagnosis of growth hormone deficiency, risks associated with use of recombinant growth hormone therapies and off-label HGH use which, to an extent, are hindering the growth and development of the same.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
The Growth Hormone market is expected to grow on account of long acting therapies and the growth is also coming from approval of new agents… Global Human Growth Hormones Market by Value (2010-2015*) 3.5
25%
3
20% 15%
2.5
10%
n ilo B $ S U
2
5%
1.5
0%
1
-5%
0.5
-10%
0
-15% Sales Value
Annual Growth
In 2014, the global market for human growth hormone reached US$... billion based on key drug sales, a decline of …% compared to US$... billion in 2013 registering a CAGR of …% from 2010-2014. The HGH market reached … Kg in terms of volume from … Kg in the previous fiscal registering an annual growth rate of …%. During 2010-2014, the market registered a CAGR of …%. The key products representing global HGH market included NovoNordisk’s Norditropin, which constituted around ..% of the global market share, Pfizer’s Genotropin with ..%, followed by Eli Lilly’s Humatrope with ..% and Sandoz’s Omnitrope with ..% share in 2014. The human growth hormone market grew rigorously in the developed geographies like the US, Canada, Europe, and Japan.
Global Human Growth Hormones Market by Volume (2010-2015*)
80
16%
70
14%
60
12% 10%
50
8%
40
6%
30
s() Kilogram
Global HGH Market Share (2014)
4%
20
2%
10
0%
0
-2% Salesa Volume
Annual Growth
Novo Nordisk
Pfizer
Lilly
Sandoz
Merck Kgaa
Roche
Others
In 2014, the global market for human growth hormone reached US$... billion based on key drug sales….
Global HGH Sales by Growth Disorder Indication ( 2015E) The primary indications in children are pediatric GHD which is estimated to have a maximum contribution of …% followed by idiopathic short stature (ISS) with a contribution of …% of the total revenue. The third highest contributor is Turner syndrome with …% share. The global market is estimated to be split roughly by ..-..% use in pediatrics and ..-..% use in adults. The worldwide pediatric growth hormone deficiency market is estimated to grow to US$... million by 2020 from US$... million in 2014. The estimated annual growth rate was ..% for 2014.
Pediatric GHD Adult GHD Others
Idiopathic Short Stature Prader-Willi
Turner Syndrome Short for Gestational Age
The US pediatric GHD market is estimated to reach US$... million in 2020 from US$... million in 2014. The annual growth rate for 2014 stood at …% and is estimated to reach …% by 2020.
Worldwide Pediatric GHD Market Opportunity (2014-20120E)
2000
n ilo S$M U
1500 1000 500 0
800
14%
8%
700
7%
12%
600
6%
500
5%
400
4%
300
Annual Growth
10% 8% 6% 4%
3%
200
2%
100
2%
1%
0
0%
0% Sales Value
n ilo S$M U
2500
The U.S. Pediatric GHD Market (2014-2020E)
Sales
Annual Growth
Given the multiple diseases that can be treated with rGH and concordant increasing use of treatment, the market has been growing continuously… European Pediatric GHD Market (2014- 2020E) 900
6%
800
5%
700 600
4%
n ilo M $ S U
500
3%
400 300
2%
200
1%
100 0
0% Sales
Annual Growth
Japan’s Pediatric GHD Market (2014- 2020E)
The European pediatric GHD market is estimated to reach US$... million by 2020 from US$... million in 2014. The market is estimated to experience modest growth along with estimated penetration of ..% within 7 years from 2014. Japan’s market for GHD is estimated to reach US$... million by 2020 from US$... million in 2014. The annual growth rate for 2014 stood at …%. After the anticipated launch, the global opportunity for VRS-317 is estimated to be US$... million for the year 2018, and is further expected to be worth US$... million by 2024, at a CAGR of …%. The global HGH market is forecasted to reach US$... billion in 2018 as compared to US$... billion in 2015.The same is expected to record a CAGR of about …% for the period spanning 2012 to 2018. Global Human Growth Hormones Market Forecast (2012-2018E)
800
8%
600
6%
400
4%
200
2%
0
0% Sales
Annual Growth
3.5 3 2.5 2
n ilo S$B U
n ilo M S$ U
4
1.5 1 0.5 0
Contact Us:Details View Report These are abridged and sanitized sample pages from the comprehensive report on the “ Global Human Growth Hormone Market ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com